Selected Tag: Gland Pharma

Selected Tag: Gland Pharma

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

Gland Pharma Gets GMP Nod From Danish Regulator For Hyderabad Facility

BasisPoint Insight

July 14, 2025 at 9:16 AM IST

US FDA Closes Inspection Of Gland Pharma’s Vizag Sterile API Facility

BasisPoint Insight

June 25, 2025 at 11:55 AM IST

Gland Pharma Says Cenexi’s Compliance Measures Cleared By French Regulator

BasisPoint Insight

June 5, 2025 at 9:51 AM IST

Gland Pharma Gets US FDA Nod For Generic Angiotensin II

BasisPoint Insight

June 4, 2025 at 7:55 AM IST

Gland Pharma Gets USFDA Nod For Glaucoma Drug, Secures 180-Day Exclusivity

BasisPoint Insight

May 2, 2025 at 2:36 AM IST

The Bureau

RBI Reopens Rate Door, December Cut Alive

US Shutdown Uncertainty Fuels Safe-Haven Demand, Drive Dollar Weakness

Benign Inflation, External Risks Keep Rate-Cut Debate Open, But for December

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics

Moody’s Affirms India at Baa3, Flags Fiscal Constraints and Tariff Uncertainty

India’s Second Half Borrowing Plan Balances Market Needs, But Yield Relief Hinges on RBI

Eight Years, Many Judgements Later Bhushan Power Stays with JSW

Venkat Chalasani on AMFI, Ethics, and Financial Literacy

Jallikattu: Tamil Nadu’s Ancient Bull-Taming Tradition